MedPath

Erasmus University Medical Center

Erasmus University Medical Center logo
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

593

Active:79
Completed:168

Trial Phases

5 Phases

Phase 1:58
Phase 2:26
Phase 3:33
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (333 trials with phase data)• Click on a phase to view related trials

Not Applicable
178 (53.5%)
Phase 1
58 (17.4%)
Phase 4
38 (11.4%)
Phase 3
33 (9.9%)
Phase 2
26 (7.8%)

Translesional PRESSURE Measurements to Assess Clinical Relevance of a Mesenteric Artery Stenosis (PRESSURE-study)

Recruiting
Conditions
Chronic Mesenteric Ischemia
Ischemia, Mesenteric
First Posted Date
2025-07-10
Last Posted Date
2025-07-10
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
125
Registration Number
NCT07059520
Locations
🇳🇱

Medisch Spectrum Twente, Enschede, Overijssel, Netherlands

🇳🇱

Erasmus University Medical Centre Rotterdam, Rotterdam, Zuid-Holland, Netherlands

🇳🇱

Franciscus, Rotterdam, Zuid-Holland, Netherlands

Steatosis Assessment Pre-LDLT

Conditions
Living Donor Liver Transplantation
First Posted Date
2025-06-11
Last Posted Date
2025-06-18
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
90
Registration Number
NCT07015723
Locations
🇳🇱

Erasmus Medical Center, Rotterdam, South Holland, Netherlands

Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients

Phase 2
Terminated
Conditions
Neuroendocrine (NE) Tumors
Interventions
First Posted Date
2025-06-10
Last Posted Date
2025-06-10
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
111
Registration Number
NCT07012330

Accuracy and Sustainability of SCALE-EYE Evaluation for Measuring Reliable Polyp Size

Not Applicable
Not yet recruiting
Conditions
Colorectal Polyps
First Posted Date
2025-06-05
Last Posted Date
2025-06-05
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
241
Registration Number
NCT07005453

Alveolar Ridge Preservation Versus Spontaneous Healing

Not Applicable
Not yet recruiting
Conditions
Dental Implants, Single-tooth
Alveolar Ridge Preservation
Guided Bone Regeneration
First Posted Date
2025-06-03
Last Posted Date
2025-06-03
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
66
Registration Number
NCT07001345
Locations
🇳🇱

Erasmus MC, Rotterdam, Zuid Holland, Netherlands

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 87
  • Next

News

€26.2 Million GREG Initiative Launches to Transform Real-World Evidence Practices Across Europe

The GREG initiative, a five-year €26.2 million public-private partnership, has launched to advance Real-World Evidence practices for medicines and medical devices evaluation across Europe.

Socioeconomic Factors and Parental Smoking Linked to Worse MS Outcomes in Children

Children from socioeconomically disadvantaged backgrounds show more severe brain inflammation and tissue loss when diagnosed with multiple sclerosis, according to a new study published in Neurology.

AIM ImmunoTech Advances to Phase 2 Trial of Ampligen-Imfinzi Combination for Late-Stage Pancreatic Cancer

Safety Committee grants approval for Phase 2 portion of AIM ImmunoTech's Phase 1b/2 trial evaluating Ampligen in combination with AstraZeneca's Imfinzi for late-stage pancreatic cancer treatment.

© Copyright 2025. All Rights Reserved by MedPath